Effect Of Isoflavones On Lipids And Bone Turnover Markers In Menopausal Women
| Effect | None |
| Trial Design | Double blind |
| Trial Length | 1-6 months |
| Number of Subjects | 252 |
| Gender | Female |
| Age Range | 45-64 |
| Body Types | Overweight |
Supplementation of 40mg Promensil twice daily failed to significantly influence all biomarkers of circulating cholesterol, although there appeared to be a slight reduction in triglycerides in the whole group (9.7%) which was significantly higher with those having higher baseline triglycerides. Biomarkers of bone metabolism (urinary N-Tx and serum osteocalcin) were not changed significantly.